Authors
Emilio Russo, Antonio Leo, Roberta Roberti, Maria Pisano, Brunella Piro, Adele Emanuela De Francesco, Luca Gallelli, Maria Cristina Caroleo
Published in
Expert opinion on drug safety. Nov 11, 2026. Epub Nov 11, 2026.
Abstract
Frail patients face changing medication-related risks that require repeated clinical reassessment. We propose a learning pharmacovigilance framework that connects safety evidence with medication decisions and outcomes.
We searched PubMed/MEDLINE and Scopus on 8 September 2026 for publications from 2015-2026; we searched ClinicalTrials.gov on the same date. We purposively selected articles for this narrative review. Six layers connect pharmacological knowledge, longitudinal data, artificial intelligence, clinical translation, outcome capture, and governed learning. We distinguish prognosis, clinical causal attribution, and treatment-effect estimation, and examine frailty assessment, prescribing-optimization trials, large language models, and regulatory requirements for updates. Clinical translation assigns responsibility for medication review, decisions, and follow-up. Outcome assessment includes withdrawal events, while implementation requires workload assessment and silent prospective testing.
Four randomized trials of prescribing optimization did not demonstrate significant benefit on their primary clinical outcomes; the integrated framework remains clinically unvalidated. Comparative evaluation should separate the contribution of structured clinical review from that of outcome-linked updating; over the next five years, we expect local model control and version traceability to become priorities for regulated medication-safety applications.
PMID:
43013403
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0